Experienced in the development and manufacture of oral dosage forms for cardiovascular, gastrointestinal, endocrine, CNS conditions and infectious diseases. Our manufacturing facilities are equipped to produce over 3 billion immediate and controlled release tablets and capsules yearly.
Frontier Biotechnologies Inc. is a research-based pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing significant unmet medical needs. - Its lead product candidate ALBUVIRTIDE, a novel long-acting anti-HIV agent. - The second lead drug candidate AB001 is a third generation topical patch for the management of pain and inflammation, and a phase 2 clinical trial of AB001 for the treatment of chronic low back pain was successfully completed in the US. - Frontier Biotechnologies, Inc., announced it has signed an agreement with The Rockefeller University of the US for the worldwide license for combining 3BNC117, a novel broad-spectrum HIV neutralizing antibody, with ALBUVIRTIDE for the treatment and prophylaxis of HIV infection and AIDS.
Fuan Group, whose predecessor is Fuan Pharmaceutical Co., Ltd, established in 2004, is specialized in researching, manufacturing and marketing of intermediates, APIs and finished products. Fuan Group has established a strict quality assurance system and EHS system. The production is organized strictly according to GMP. Main products meet FDA and EDQM requirements. Fuan also can supply customers with CTD-DMF documents. With stable and high quality, our products are exported to overseas, including USA, Europe, Asia, South America and etc. As a high tech enterprise, Fuan Group IPO in March 2011. Under the core value of unity, enterprising, innovation and honesty, Fuan Group is on the way to become the leading pharmaceutical company in China and actively enter the international market.
Chemical Industries Co Ltd is a leading manufacturer of Active Pharmaceutical
Ingredients, Drug Products, Excipients and Natural Astaxanthin. Our specialized
contract manufacturing offers API synthesis, solid dispersion with our spray
drying technology, etc. Additionally, we offer unique excipients for oral
dosage forms, such as Neusilin, Fujicalin. and F-MELT.
Fujian Fukang Pharmaceutical Co., Ltd was reformed into a corporation with a variety of shareholders in 2002. Its current product range includes 7ACA intermediate, sterile cephalosporin API, antibiotic API, and Animal Feed. Kinds of Fukang's antibiotic APIs have been approved by US FDA or have obtained COS and EU GMP Certificate. As one of the top 100 pharmaceutical enterprises in China, Fukang has successfully established and maintained a long-term and sound business relationship with more than 100 companies over the world.
Fujian South Pharmaceutical Co Ltd (FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has become an important cGMP manufacturer for oncology APIs in China. FSP cultivates 7,000 acres of Taxus Wallichiana (Taxus yunnanensis), and it is the largest commercial utilizing in China. FSP is the main supplier for natural Paclitaxel, semi-synthesis Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana) in the world. FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc. FSP is strong in R&D, with a pathbreaking team in Shanghai R&D Center. We hold 6 PCT patents and 33 China patents for processing of taxanes, tabines and tinibs. FSP endeavors to become a well-known oncology pharmaceutical company in the world in next decade.
Established in 2000,Zhejiang Materials Chongyi Med & Che. Co Ltd, is a leading pharmaceutical company, with its focus on the production of pharmaceutical API, pharmaceutical intermediates and fine chemicals. In 2011 it invested in a new factory in Fujian Province, and Fujian Wanke Pharmaceutical Co Ltd, was established
Fujian Wanke Pharmaceutical Co Ltd, a high-tech enterprise, that specializes in the research, development and production of pharmaceutical materials and intermediates for age-related diseases (e.g. Hypertension, diabetes), antiviral and anticancer drugs. With rich experience for many years, the company has formed a complete system of research and development, production and marketing.
FUJIFILM Diosynth Biotechnologies is a Global Contract Development and Biomanufacturing Organisation, offering services in process development, analytics and cGMP production for recombinant proteins and viral products, from first in man to commercial. With 1200 staff, including 250 process scientists, and cGMP up to 5000L, we have the capability to support the full drug life cycle.
Long recognized as a world-renowned supplier of high purity chemicals, FUJIFILM Wako Chemicals U.S.A. Corporation proudly introduces its new line of PYROSTAR ES-F reagents, instrumentation and consumables for the specific determination of bacterial endotoxin. This line represents the culmination of more than 30 years of research and development dedicated to providing customers with endotoxin-specific products for every user and every method. FUJIFILM Wako invites you to visit the company at CPhI Worldwide, Hall H3, Stand 3H35, to learn more about its products and discover how FUJIFILM can provide solutions to support all of your endotoxin testing needs.
Established in 2001, Fuxin Jintelai Fluorine Chemical Co Ltd is one of the manufacturers engaging in the production of fluorine-contained pharmaceutical and pesticide intermediates, it covers an area of 30000m2. Our main products include:- benzotrifluoride, methylbenzene containing fluorine, benzoic acid containing fluorine, pyridine containing fluorine, benzaldehyde containing fluorine